Commercial Open Source Biotechnology
"A number of for-profit biotechnology companies have been inspired by the success of open source software enterprises to pursue business models that differ from the more conventional monopoly-based approach.
One example is Diversity Arrays Technology (DArT), a privately held Australian company established in 2001 to commercialize a patented molecular marker technology invented by its founder and director, Andrzej Kilian. The company’s non-proprietary, service-based business model has been inspired by that of Red Hat, the successful Linux distribution company whose initial public offering made Wall Street history in August 1999. DArT offers a concrete illustration of the distinctive commercial logic underpinning open source biotechnology. Instead of relying on injections of funds from capital markets supplemented by licensing revenue, the company’s business model is designed to exploit the synergy between service provision and ongoing technology development." (http://opensourcebiotech.anu.edu.au/Open_Source_Biotechnology/Practice.html)